A Study of BMS-863233 in Patients With Advanced and/or Metastatic Solid Tumors
Status:
Terminated
Trial end date:
2010-08-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine safety, tolerability and maximum tolerated dose of
BMS-863233 in subjects advanced and/or Metastatic solid tumors.